Efficacy and Safety of FEIBA Prophylaxis Evaluation in Young Patients With Haemophilia and High Titer Inhibitor

被引：0
|
作者：
Karimi, M. [1 ]
Tavoosi, H. [1 ]
Haghpanah, S. [1 ]
Ardeshiri, R. [1 ]
Zarei, T. [1 ]
机构：
[1] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
来源：
HAEMOPHILIA | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP049
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A
    Young, J. -H.
    Liu, H. -C.
    Hsueh, E. -J.
    Huang, M. -L.
    Peng, C. -T.
    Chen, R. -L.
    Maas-Enriquez, M.
    Achilles, K.
    HAEMOPHILIA, 2009, 15 (04) : 968 - 970
  • [42] Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial
    Yang, Renchi
    Sun, Jing
    Zhao, Yongqiang
    Wang, Xuefeng
    Wu, Depei
    Tseneklidou-Stoeter, Despina
    Wu, Junde
    Church, Nikki
    HAEMOPHILIA, 2019, 25 (03) : E153 - E158
  • [43] Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome
    Agosti, Pasquale
    Siboni, Simona Maria
    Ciavarella, Alessandro
    Arcudi, Sara
    Boggio, Federico
    Gualtierotti, Roberta
    Peyvandi, Flora
    HAEMOPHILIA, 2024, 30 (02) : 336 - 344
  • [44] Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study
    Holme, Pal Andre
    Poulsen, Lone Hvitfeldt
    Tueckmantel, Claudia
    Enriquez, Monika Maas
    Roman, Maria Teresa Alvarez
    De Cristofaro, Raimondo
    HAEMOPHILIA, 2024, 30 (02) : 388 - 394
  • [45] Efficacy And Safety Of Kcentra Versus Feiba In Patients With Intracerebral Hemorrhage Secondary To Oral Anticoagulants
    Ishfaq, Muhammad
    Bhagavan, Sachin
    Ishfaq, Ammad
    Kumar, Mukaish
    Pulimamidi, Shruthi
    Qualls, Kathryn
    French, Brandi
    Siddiq, Farhan
    Gomez, Camilo
    Qureshi, Adnan
    NEUROLOGY, 2021, 96 (15)
  • [46] Cost simulation of novoseven versus FEIBA and ITT-F8 for primary prophylaxis treatment of haemophilia A/B patients with inhibitors
    Weatherall, J. H.
    VALUE IN HEALTH, 2007, 10 (06) : A281 - A281
  • [47] Emicizumab prophylaxis in a Korean child with severe hemophilia A and high titer inhibitor: a case report
    Ahn, Ji Hyun
    Jung, Nani
    Shim, Ye Jee
    Kim, Heung Sik
    BLOOD RESEARCH, 2021, 56 (01) : 44 - 46
  • [48] Haemophilia prophylaxis in young patients - a long-term follow-up
    Lofqvist, T
    Nilsson, IM
    Berntorp, E
    Pettersson, H
    JOURNAL OF INTERNAL MEDICINE, 1997, 241 (05) : 395 - 400
  • [49] Adherence to Prophylaxis in Adolescents and Young Adults with Severe Haemophilia: A Quantitative Study with Patients
    van Os, Sandra B.
    Troop, Nick A.
    Sullivan, Keith R.
    Hart, Daniel P.
    PLOS ONE, 2017, 12 (01):
  • [50] SAFETY AND EFFICACY OF HIGH-DOSE, PLASMA-DERIVED FVIII IN PATIENTS WITH ACQUIRED HAEMOPHILIA A
    Di Prinzio, G.
    Goldmann, G.
    Horneff, S.
    Klein, C.
    Marquardt, N.
    Nadal, J.
    Oldenburg, J.
    HAEMOPHILIA, 2021, 27 : 127 - 127
12345